Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Ardelyx Inc (NQ: ARDX)
7.181 USD  -0.139 (-1.89%)
Streaming Delayed Price  /  Updated: 1:37 PM EST, Jan 28, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 199,882
Open 7.370
Bid (Size) 7.170 (1)
Ask (Size) 7.190 (6)
Prev. Close 7.320
Today's Range 7.160 - 7.490
52wk Range 1.960 - 8.490
Shares Outstanding 60,103,568
Dividend Yield N/A
Performance
YTD
-2.30%
-2.30%
1 Month
-3.35%
-3.35%
3 Month
+43.34%
+43.34%
6 Month
+197.98%
+197.98%
1 Year
+260.87%
+260.87%
Top News
More News
Ardelyx Announces Pricing of Upsized Public Offering of Common Stock
Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with cardiorenal diseases, today... Read More
from PR Newswire
Ardelyx Announces Proposed Public Offering of Common Stock
Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with cardiorenal diseases, today... Read More
from PR Newswire
More News
Read More
3 Penny Stocks To Watch Making New December Highs; 1 Up 74% This Quarter
from Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
How The Parts Add Up: PTH Targets $106
category ETFs
from ETF Channel
Ardelyx Announces Positive Topline Results from Pivotal Phase 3 PHREEDOM Study Evaluating Tenapanor in CKD Patients on Dialysis
from PR Newswire
First Week of February 2020 Options Trading For Ardelyx (ARDX)
category Stocks
from Market News Video
Double Your Money with This Biotech
category AGN , IRWD , BHC , and 3 more.
from Motley Fool
UPDATE 2-Ardelyx drug reduces elevated phosphate levels, late-stage study shows
category companyNews
from Reuters: Company News
UPDATE 1-Ardelyx's kidney disease drug reduces elevated phosphate levels in late-stage study
category companyNews
from Reuters: Company News
Ardelyx's kidney disease drug reduces elevated phosphate levels in late-stage study
category companyNews
from Reuters: Company News
Why Ardelyx Shares Jumped Today
category Market News , ARDX
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.